1. Repository of OAI
Ελληνικά   English  

Browsing by Author Levin, V. A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 24 to 43 of 47 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agentsKyritsis, A. P.; Bondy, M. L.; Levin, V. A.24-Nov-2015-
Multifocal cerebral gliomas associated with secondary malignanciesKyritsis, A. P.; Yung, W. K.; Leeds, N. E.; Bruner, J.; Gleason, M. J.; Levin, V. A.24-Nov-2015-
Mutagen sensitivity and risk of gliomas: a case-control analysisBondy, M. L.; Kyritsis, A. P.; Gu, J.; de Andrade, M.; Cunningham, J.; Levin, V. A.; Bruner, J. M.; Wei, Q.24-Nov-2015-
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivoFueyo, J.; Gomez-Manzano, C.; Alemany, R.; Lee, P. S.; McDonnell, T. J.; Mitlianga, P.; Shi, Y. X.; Levin, V. A.; Yung, W. K.; Kyritsis, A. P.24-Nov-2015-
Mutations of the p16 gene in gliomasKyritsis, A. P.; Zhang, B.; Zhang, W.; Xiao, M.; Takeshima, H.; Bondy, M. L.; Cunningham, J. E.; Levin, V. A.; Bruner, J.24-Nov-2015-
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trialsWong, E. T.; Hess, K. R.; Gleason, M. J.; Jaeckle, K. A.; Kyritsis, A. P.; Prados, M. D.; Levin, V. A.; Yung, W. K.24-Nov-2015-
Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivoFueyo, J.; Gomez-Manzano, C.; Yung, W. K.; Liu, T. J.; Alemany, R.; McDonnell, T. J.; Shi, X.; Rao, J. S.; Levin, V. A.; Kyritsis, A. P.24-Nov-2015-
Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survivalPuduvalli, V. K.; Kyritsis, A. P.; Hess, K. R.; Bondy, M. L.; Fuller, G. N.; Kouraklis, G. P.; Levin, V. A.; Bruner, J. M.24-Nov-2015-
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiformeLevin, V. A.; Maor, M. H.; Thall, P. F.; Yung, W. K.; Bruner, J.; Sawaya, R.; Kyritsis, A. P.; Leeds, N.; Woo, S.; Rodriguez, L.; et al.,24-Nov-2015-
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiformeGroves, M. D.; Maor, M. H.; Meyers, C.; Kyritsis, A. P.; Jaeckle, K. A.; Yung, W. K.; Sawaya, R. E.; Hess, K.; Bruner, J. M.; Peterson, P.; Levin, V. A.24-Nov-2015-
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomasFine, H. A.; Figg, W. D.; Jaeckle, K.; Wen, P. Y.; Kyritsis, A. P.; Loeffler, J. S.; Levin, V. A.; Black, P. M.; Kaplan, R.; Pluda, J. M.; Yung, W. K.24-Nov-2015-
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiformeLevin, V. A.; Uhm, J. H.; Jaeckle, K. A.; Choucair, A.; Flynn, P. J.; Yung, W. K. A.; Prados, M. D.; Bruner, J. M.; Chang, S. M.; Kyritsis, A. P.; Gleason, M. J.; Hess, K. R.24-Nov-2015-
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomasLevin, V. A.; Hess, K. R.; Choucair, A.; Flynn, P. J.; Jaeckle, K. A.; Kyritsis, A. P.; Yung, W. K.; Prados, M. D.; Bruner, J. M.; Ictech, S.; Gleason, M. J.; Kim, H. W.24-Nov-2015-
Prognostic significance of p53 immunoreactivity in patients with gliomaKyritsis, A. P.; Bondy, M. L.; Hess, K. R.; Cunningham, J. E.; Zhu, D.; Amos, C. J.; Yung, W. K.; Levin, V. A.; Bruner, J. M.24-Nov-2015-
Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomasWei, Q.; Bondy, M. L.; Mao, L.; Gaun, Y.; Cheng, L.; Cunningham, J.; Fan, Y.; Bruner, J. M.; Yung, W. K.; Levin, V. A.; Kyritsis, A. P.24-Nov-2015-
Response and progression in recurrent malignant gliomaHess, K. R.; Wong, E. T.; Jaeckle, K. A.; Kyritsis, A. P.; Levin, V. A.; Prados, M. D.; Yung, W. K.24-Nov-2015-
Risk assessment for developing gliomas: a comparison of two cytogenetic approachesEl-Zein, R.; Bondy, M. L.; Wang, L. E.; de Andrade, M.; Sigurdson, A. J.; Bruner, J. M.; Kyritsis, A. P.; Levin, V. A.; Wei, Q.24-Nov-2015-
A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolutionWooten, E. C.; Fults, D.; Duggirala, R.; Williams, K.; Kyritsis, A. P.; Bondy, M. L.; Levin, V. A.; O'Connell, P.24-Nov-2015-
Suppression of human glioma growth by adenovirus-mediated Rb gene transferFueyo, J.; Gomez-Manzano, C.; Yung, W. K.; Liu, T. J.; Alemany, R.; Bruner, J. M.; Chintala, S. K.; Rao, J. S.; Levin, V. A.; Kyritsis, A. P.24-Nov-2015-
A systematic approach to the management of patients with brain metastases of known or unknown primary siteKyritsis, A. P.; Markoula, S.; Levin, V. A.24-Nov-2015-
Showing results 24 to 43 of 47 < previous   next >